Graft of Autologous minimally manipulated homologous adipose (AMHAT) treatment of chronic wound, DFU

dc.contributor.author	Ethiopian Food and Drug Authority
dc.date.accessioned	2026-02-24T06:52:18Z
dc.date.available	2026-02-24T06:52:18Z
dc.date.issued	2024
dc.identifier.uri	http://repository.iphce.org/xmlui/handle/123456789/5322
dc.description.abstract	Diabetic foot ulcers (DFUs) are a significant public health concern in Ethiopia, with a prevalence rate of 12.98% among diabetic patients. The highest prevalence is observed in Addis Ababa, with a rate of 19.31%. DFUs are one of the leading reasons for hospital admissions, amputations, and even death among diabetic patients in Ethiopia.	en_US
dc.language.iso	en_US	en_US
dc.subject	Wounds	en_US
dc.title	Graft of Autologous minimally manipulated homologous adipose (AMHAT) treatment of chronic wound, DFU	en_US
dc.title.alternative	AMHAT trial	en_US
dc.type	Report	en_US